Warren D. Cooper

Invests in

Biotech

Colleagues at HEALTHCARE ROYALTY PARTNERS

AB

Aaron B. Simon

Associate at HEALTHCARE ROYALTY PARTNERS

AJ

Amy J. Zacharias

Senior Vice President and Controller at HEALTHCARE ROYALTY PARTNERS

AL

Andrew Logerfo

Vice President at HEALTHCARE ROYALTY PARTNERS

CM

Carlos M. Almodóvar

Chief Business Officer at HEALTHCARE ROYALTY PARTNERS

CA

Christopher A. White

President and Chief Financial Officer at HEALTHCARE ROYALTY PARTNERS

CB

Clarke B. Futch

Chairman and Chief Executive Officer at HEALTHCARE ROYALTY PARTNERS

DO

David Oron

Analyst at HEALTHCARE ROYALTY PARTNERS

EY

Eric Yoo

Vice President, PharmD at HEALTHCARE ROYALTY PARTNERS

Frequently asked questions

Who is Warren D. Cooper?

Warren D. Cooper is Chief Medical Officer at HCRx, where he also heads the Portfolio Management Committee and chairs the Senior Advisor Board, having previously advised the firm. A UK-trained physician with a background in cardiology and cardiac surgery, he spent 12 years at Merck, ultimately leading worldwide clinical research operations for Merck Research Laboratories, and later ran the cardiovascular business division at AstraMerck (now AstraZeneca). He was founding CEO of Prism Pharmaceuticals, which was sold to Baxter International, and holds degrees in physiology, medicine, and surgery from The London Hospital (University of London).

Where does Warren D. Cooper work?

Warren D. Cooper is Chief Medical Officer at HEALTHCARE ROYALTY PARTNERS.

What does Warren D. Cooper invest in?

Warren D. Cooper invests in Biotech.